$LSF
Laird Superfood, Inc.

2020 Q4 Form 10-Q Financial Statement

#000119312520291793 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $7.285M $7.491M $3.487M
YoY Change 74.65% 114.8%
Cost Of Revenue $5.820M $5.734M $2.027M
YoY Change 113.76% 182.9%
Gross Profit $1.465M $1.756M $1.460M
YoY Change 1.14% 20.27%
Gross Profit Margin 20.11% 23.45% 41.88%
Selling, General & Admin $5.828M $5.035M $3.761M
YoY Change 64.76% 33.87%
% of Gross Profit 397.81% 286.68% 257.56%
Research & Development $144.2K $102.9K $110.0K
YoY Change 4.58% -6.45%
% of Gross Profit 9.84% 5.86% 7.53%
Depreciation & Amortization $130.5K $114.9K
YoY Change -56.59%
% of Gross Profit 8.91% 6.54%
Operating Expenses $5.972M $5.138M $3.871M
YoY Change 62.5% 32.73%
Operating Profit -$4.507M -$3.382M -$2.411M
YoY Change 102.42% 40.27%
Interest Expense $13.42K $26.75K $18.83K
YoY Change 42.07%
% of Operating Profit
Other Income/Expense, Net $0.00 $26.75K $37.77K
YoY Change -100.0% -29.19%
Pretax Income -$4.494M -$3.355M -$2.373M
YoY Change 108.12% 41.37%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.494M -$3.355M -$2.373M
YoY Change 108.12% 41.37%
Net Earnings / Revenue -61.69% -44.79% -68.05%
Basic Earnings Per Share -$0.86 -$0.66
Diluted Earnings Per Share -$510.0K -$0.86 -$0.66
COMMON SHARES
Basic Shares Outstanding 8.875M 4.672M 3.593M
Diluted Shares Outstanding 4.672M 3.593M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $65.68M $73.43M
YoY Change 912.14%
Cash & Equivalents $56.97M $72.95M $7.538M
Short-Term Investments $8.707M $480.7K
Other Short-Term Assets $51.11K $55.65K
YoY Change 15.49%
Inventory $6.296M $3.878M
Prepaid Expenses
Receivables $839.7K $782.5K
Other Receivables $97.67K $95.61K
Total Short-Term Assets $76.00M $80.36M
YoY Change 656.61%
LONG-TERM ASSETS
Property, Plant & Equipment $3.513M $3.209M
YoY Change 11.42%
Goodwill $0.00
YoY Change
Intangibles $137.1K
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.992K $7.544K
YoY Change -67.03%
Total Long-Term Assets $6.347M $6.385M
YoY Change -0.17%
TOTAL ASSETS
Total Short-Term Assets $76.00M $80.36M
Total Long-Term Assets $6.347M $6.385M
Total Assets $82.34M $86.74M
YoY Change 402.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.316M $2.339M
YoY Change 81.57%
Accrued Expenses $704.5K $868.1K
YoY Change 134.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.743M $3.905M
YoY Change 80.86%
LONG-TERM LIABILITIES
Long-Term Debt $51.00K $51.00K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $51.00K $51.00K
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.743M $3.905M
Total Long-Term Liabilities $51.00K $51.00K
Total Liabilities $2.794M $3.956M
YoY Change 78.23%
SHAREHOLDERS EQUITY
Retained Earnings -$31.93M -$27.43M
YoY Change 67.36%
Common Stock $111.5M $110.2M
YoY Change 309.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $79.55M $82.79M -$392.6K
YoY Change
Total Liabilities & Shareholders Equity $82.34M $86.74M
YoY Change 402.02%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$4.494M -$3.355M -$2.373M
YoY Change 108.12% 41.37%
Depreciation, Depletion And Amortization $130.5K $114.9K
YoY Change -56.59%
Cash From Operating Activities -$7.586M -$2.451M
YoY Change -19.58%
INVESTING ACTIVITIES
Capital Expenditures -$185.1K -$562.0K
YoY Change -92.36%
Acquisitions
YoY Change
Other Investing Activities -$8.213M $4.322M
YoY Change 49.11%
Cash From Investing Activities -$8.398M $3.760M
YoY Change 5.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 244.2K 63.09M
YoY Change -76.27%
NET CHANGE
Cash From Operating Activities -7.586M -2.451M
Cash From Investing Activities -8.398M 3.760M
Cash From Financing Activities 244.2K 63.09M
Net Change In Cash -15.74M 64.40M
YoY Change -3.65%
FREE CASH FLOW
Cash From Operating Activities -$7.586M -$2.451M
Capital Expenditures -$185.1K -$562.0K
Free Cash Flow -$7.401M -$1.889M
YoY Change 5.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
590808
CY2020Q3 us-gaap Deposit Assets
DepositAssets
95619
CY2019Q4 us-gaap Deposit Assets
DepositAssets
143327
CY2020Q3 us-gaap Assets Current
AssetsCurrent
80357380
CY2019Q4 us-gaap Assets Current
AssetsCurrent
10044224
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3208853
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3153286
CY2020Q3 us-gaap Disposal Group Including Discontinued Operation Property Plant And Equipment
DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment
250000
CY2020Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
132100
CY2019Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
132100
CY2020Q3 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
2786701
CY2019Q4 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
3057432
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72947685
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1004109
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
782475
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
384806
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
480747
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
5485209
CY2020Q3 us-gaap Inventory Net
InventoryNet
3877731
CY2019Q4 us-gaap Inventory Net
InventoryNet
2435965
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2173123
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7544
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15143
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
6385198
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
6357961
CY2020Q3 us-gaap Assets
Assets
86742578
CY2019Q4 us-gaap Assets
Assets
16402185
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2338505
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
724751
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
698767
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
491092
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
868149
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
301046
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3905421
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1516889
CY2020Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
51000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
51000
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
51000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
51000
CY2020Q3 us-gaap Liabilities
Liabilities
3956421
CY2019Q4 us-gaap Liabilities
Liabilities
1567889
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
6722951
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
8875
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
4188
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
110210155
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27184250
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
698
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-226
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27433571
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19076867
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
82786157
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8111345
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86742578
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16402185
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
6722951
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5000000
CY2019Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
1329680
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9600000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9239638
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8874890
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4551950
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4188558
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7613073
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3487335
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18705128
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8932642
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5734144
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2026930
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13384880
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5296485
CY2020Q3 us-gaap Gross Profit
GrossProfit
1878929
CY2019Q3 us-gaap Gross Profit
GrossProfit
1460405
us-gaap Gross Profit
GrossProfit
5320248
us-gaap Gross Profit
GrossProfit
3636157
CY2020Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1031425
CY2019Q3 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
637913
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
2652500
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1758080
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
290148
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
145281
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
589600
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
436996
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
274244
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
143424
us-gaap Professional Fees
ProfessionalFees
647422
CY2019Q3 lsf Office Expenses
OfficeExpenses
125594
us-gaap Professional Fees
ProfessionalFees
362134
CY2020Q3 lsf Office Expenses
OfficeExpenses
142269
lsf Research And Development Expenses Salaries And Wages
ResearchAndDevelopmentExpensesSalariesAndWages
202287
lsf Research And Development Expenses Salaries And Wages
ResearchAndDevelopmentExpensesSalariesAndWages
132691
CY2020Q3 lsf Research And Development Expenses Stock Based Compensation
ResearchAndDevelopmentExpensesStockBasedCompensation
2310
CY2019Q3 lsf Research And Development Expenses Stock Based Compensation
ResearchAndDevelopmentExpensesStockBasedCompensation
2045
lsf Research And Development Expenses Stock Based Compensation
ResearchAndDevelopmentExpensesStockBasedCompensation
6694
lsf Research And Development Expenses Stock Based Compensation
ResearchAndDevelopmentExpensesStockBasedCompensation
5549
CY2020Q3 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
46115
lsf Office Expenses
OfficeExpenses
364518
lsf Office Expenses
OfficeExpenses
306075
CY2020Q3 us-gaap Occupancy Net
OccupancyNet
57378
CY2019Q3 us-gaap Occupancy Net
OccupancyNet
52095
us-gaap Occupancy Net
OccupancyNet
167151
us-gaap Occupancy Net
OccupancyNet
95985
CY2020Q3 lsf Merchant Service Fees
MerchantServiceFees
103306
CY2019Q3 lsf Merchant Service Fees
MerchantServiceFees
44100
lsf Merchant Service Fees
MerchantServiceFees
248355
lsf Merchant Service Fees
MerchantServiceFees
111683
CY2020Q3 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
33173
CY2019Q3 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
35125
us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
90491
us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
112559
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
239734
CY2020Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
286876
CY2019Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
192770
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
651061
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
526289
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2218819
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1376302
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5650832
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3709801
CY2020Q3 lsf Research And Development Expenses Salaries And Wages
ResearchAndDevelopmentExpensesSalariesAndWages
54454
CY2019Q3 lsf Research And Development Expenses Salaries And Wages
ResearchAndDevelopmentExpensesSalariesAndWages
77970
CY2019Q3 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
29963
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
155009
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
48172
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
102879
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
109978
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
363990
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
186412
CY2020Q3 lsf Salaries And Wages Sales And Marketing
SalariesAndWagesSalesAndMarketing
613961
CY2019Q3 lsf Salaries And Wages Sales And Marketing
SalariesAndWagesSalesAndMarketing
744964
lsf Salaries And Wages Sales And Marketing
SalariesAndWagesSalesAndMarketing
2057517
lsf Salaries And Wages Sales And Marketing
SalariesAndWagesSalesAndMarketing
1930485
CY2020Q3 lsf Stock Based Compensation Sales And Marketing
StockBasedCompensationSalesAndMarketing
520022
CY2019Q3 lsf Stock Based Compensation Sales And Marketing
StockBasedCompensationSalesAndMarketing
70271
lsf Stock Based Compensation Sales And Marketing
StockBasedCompensationSalesAndMarketing
630456
lsf Stock Based Compensation Sales And Marketing
StockBasedCompensationSalesAndMarketing
101150
CY2020Q3 us-gaap Marketing Expense
MarketingExpense
325033
CY2019Q3 us-gaap Marketing Expense
MarketingExpense
525521
us-gaap Marketing Expense
MarketingExpense
895917
us-gaap Marketing Expense
MarketingExpense
1279391
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
1250169
CY2019Q3 us-gaap Advertising Expense
AdvertisingExpense
730912
us-gaap Advertising Expense
AdvertisingExpense
3340592
us-gaap Advertising Expense
AdvertisingExpense
1998131
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
386648
CY2020Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
179425
CY2019Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
159153
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
575313
CY2020Q3 lsf Travel Expenses
TravelExpenses
4908
CY2019Q3 lsf Travel Expenses
TravelExpenses
82937
lsf Travel Expenses
TravelExpenses
78872
lsf Travel Expenses
TravelExpenses
266978
CY2020Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
45543
CY2019Q3 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
71322
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
148911
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
302517
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2939061
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2385080
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7727578
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6265300
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
5260759
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
3871360
us-gaap Operating Expenses
OperatingExpenses
13742400
us-gaap Operating Expenses
OperatingExpenses
10161513
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3381830
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2410955
us-gaap Operating Income Loss
OperatingIncomeLoss
-8422152
us-gaap Operating Income Loss
OperatingIncomeLoss
-6525356
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
20496
CY2019Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
56602
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
51521
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
149332
CY2020Q3 us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
6250
us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
13927
CY2019Q3 us-gaap Interest Expense
InterestExpense
18829
us-gaap Interest Expense
InterestExpense
18829
lsf Grant Income
GrantIncome
50000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26746
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
37773
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
65448
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
180503
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3355084
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2373182
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8356704
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6344853
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3355084
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2373182
CY2020Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2020Q3 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
645939
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4001023
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2373182
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10007436
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6344853
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.79
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.79
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4672041
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3592735
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4427114
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3541001
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Net Income Loss
NetIncomeLoss
-8356704
us-gaap Net Income Loss
NetIncomeLoss
-6344853
us-gaap Depreciation
Depreciation
344162
us-gaap Depreciation
Depreciation
198970
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-483
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1382864
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
546475
lsf Noncash Conversion Of Note Payable To Grant Income
NoncashConversionOfNotePayableToGrantIncome
50000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-13927
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
397669
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
214122
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1441766
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1402745
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1582315
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
61736
lsf Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-270731
lsf Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-163365
lsf Increase Decrease In Deposits Assets
IncreaseDecreaseInDepositsAssets
-33009
lsf Increase Decrease In Deposits Assets
IncreaseDecreaseInDepositsAssets
-3115
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7599
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3528
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1613754
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-166799
us-gaap Increase Decrease In Due To Employees Current
IncreaseDecreaseInDueToEmployeesCurrent
207675
us-gaap Increase Decrease In Due To Employees Current
IncreaseDecreaseInDueToEmployeesCurrent
318513
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
567103
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
62447
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7097896
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6943359
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
874764
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1645800
lsf Payments Towards Advances On Property Plant And Equipment To Be Acquired
PaymentsTowardsAdvancesOnPropertyPlantAndEquipmentToBeAcquired
338560
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
516459
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
13445050
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4475000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7004232
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4116695
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8425178
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
66104477
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6663910
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
10000006
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20532
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1079878
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
119838
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34667
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1131291
lsf Preferred Stock Issuance Costs
PreferredStockIssuanceCosts
147721
lsf Preferred Stock Issuance Costs
PreferredStockIssuanceCosts
52073
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
74924777
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5566626
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
71943576
us-gaap Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9801911
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17340023
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7538112
us-gaap Interest Paid Net
InterestPaidNet
18829
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
924
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
56081
CY2019Q4 lsf Purchases Of Equipment Included In Deposits
PurchasesOfEquipmentIncludedInDeposits
14699
CY2018Q4 lsf Purchases Of Equipment Included In Deposits
PurchasesOfEquipmentIncludedInDeposits
4577
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-16421
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6999
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
924
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
56081
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16421
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6999
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
924
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56081
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4017444
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2380181
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10006512
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6288772
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6289923
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
849055
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
113809
CY2020Q3 lsf Adjustment To Additional Paid In Capital Deemed Dividend On Warrant Discount
AdjustmentToAdditionalPaidInCapitalDeemedDividendOnWarrantDiscount
-645939
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
16575236
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64106869
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1131291
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-4894894
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
218524
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6663907
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-392644
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1382864
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
119838
lsf Adjustment To Additional Paid In Capital Temporary Equity Beneficial Conversion Feature
AdjustmentToAdditionalPaidInCapitalTemporaryEquityBeneficialConversionFeature
825366
lsf Adjustment To Additional Paid In Capital Deemed Dividend On Beneficial Conversion Feature
AdjustmentToAdditionalPaidInCapitalDeemedDividendOnBeneficialConversionFeature
-825366
lsf Adjustment To Additional Paid In Capital Allocation Of Preferred Proceeds To Warrant
AdjustmentToAdditionalPaidInCapitalAllocationOfPreferredProceedsToWarrant
825366
lsf Adjustment To Additional Paid In Capital Deemed Dividend On Warrant Discount
AdjustmentToAdditionalPaidInCapitalDeemedDividendOnWarrantDiscount
-825366
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
16575236
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
66104477
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1131291
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-269046
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
546475
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6663910
CY2017Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
51000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3972759
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3619359
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
763906
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
466073
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
480049
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
480747
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
480049
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
480747
CY2020Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
1580395
CY2019Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
100387
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
76576
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
37251
CY2020Q3 lsf Prepaid Software Costs
PrepaidSoftwareCosts
246295
CY2019Q4 lsf Prepaid Software Costs
PrepaidSoftwareCosts
193257
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
159944
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
71445
CY2020Q3 lsf Prepaid Consultancy Fees Current
PrepaidConsultancyFeesCurrent
27925
CY2019Q4 lsf Prepaid Consultancy Fees Current
PrepaidConsultancyFeesCurrent
69813
CY2020Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
26335
CY2019Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
74400
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
55653
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
44255
CY2020Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1864294
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1187513
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2013437
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1248452
CY2020Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6496983
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
456104
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14786
CY2020Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1575202
CY2019Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1256433
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4236509
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
3277522
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6585122
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4584174
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20532
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1079878
CY2020Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
CY2019Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00
CY2020Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020Q3 us-gaap Assets Held For Sale Long Lived Fair Value Disclosure
AssetsHeldForSaleLongLivedFairValueDisclosure
250000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4672041
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3592735
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4427114
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3541001
CY2020Q3 us-gaap Dilutive Securities
DilutiveSecurities
CY2019Q3 us-gaap Dilutive Securities
DilutiveSecurities
us-gaap Dilutive Securities
DilutiveSecurities
us-gaap Dilutive Securities
DilutiveSecurities
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4672041
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3592735
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4427114
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3541001
CY2020Q3 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
883260
CY2019Q3 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
2636440
us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
883260
us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
2636440
CY2020Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2018Q2 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
40000
CY2020Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
213532
CY2019Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
173644
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
589196
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
328422
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
58359
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0
CY2020Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
58359
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
237737
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
51000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2000948
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1665541
CY2020Q3 lsf Valuation Allowance Deferred Tax Liabilities On Unrealised Gain On Available For Sale Investments
ValuationAllowanceDeferredTaxLiabilitiesOnUnrealisedGainOnAvailableForSaleInvestments
194
CY2020Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
23955781
CY2019Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
17546110
CY2020Q3 lsf Unrecorded Tax Liabilities
UnrecordedTaxLiabilities
0
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6585122
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4584174
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
288737
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
244869
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2020Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
244869
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
252216
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2020Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
252216
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
259782
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0
CY2020Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
259782
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
0
CY2020Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
1132122
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2185085
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
51000
CY2020Q3 us-gaap Contractual Obligation
ContractualObligation
2236085
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.005
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
4623702
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
3470371
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1825296
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1285488
CY2020Q3 lsf Deferred Tax Assets Federal Depreciation And Amortisation
DeferredTaxAssetsFederalDepreciationAndAmortisation
480917
CY2019Q4 lsf Deferred Tax Assets Federal Depreciation And Amortisation
DeferredTaxAssetsFederalDepreciationAndAmortisation
53525
CY2020Q3 lsf Deferred Tax Assets State Depreciation And Amortisation
DeferredTaxAssetsStateDepreciationAndAmortisation
239166
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
88631
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
94553
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
7352265
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
4809384
CY2019Q4 lsf Deferred Tax Liabilities Federal Depreciation And Amortisation
DeferredTaxLiabilitiesFederalDepreciationAndAmortisation
179720
CY2020Q3 lsf Deferred Tax Liabilities State Depreciation And Amortisation
DeferredTaxLiabilitiesStateDepreciationAndAmortisation
0
CY2019Q4 lsf Deferred Tax Liabilities State Depreciation And Amortisation
DeferredTaxLiabilitiesStateDepreciationAndAmortisation
45490
CY2020Q3 us-gaap Deferred Tax Liabilities Deferred Expense Reserves And Accruals
DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals
767143
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
767143
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
225210
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6585122
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4584174
CY2019Q4 lsf Unrecorded Tax Liabilities
UnrecordedTaxLiabilities
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
788528
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.42
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4799381
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
164078
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.12
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.59
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M17D
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0192
dei Entity File Number
EntityFileNumber
001-39537
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
lsf Share Based Compensation Arrangement By Share Based Payment Weightedaverage Fair Value Of Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentWeightedaverageFairValueOfOptionsGranted
17.22
lsf Share Based Compensation Arrangement By Share Based Payment Weightedaverage Fair Value Of Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentWeightedaverageFairValueOfOptionsGranted
5.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
45532
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.37
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
895760
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.94
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M26D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
34313763
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
508382
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y5M8D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19851163
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
641500
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.99
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4057973
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
291500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.32
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
65566
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.31
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
850100
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M27D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4293265
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
343186
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.16
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M4D
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3231457
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11314
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
17334
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7018
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6165
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M23D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0070
CY2019Q3 us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
CY2018Q4 lsf Purchases Of Land Included In Prepaid And Other Current Assets
PurchasesOfLandIncludedInPrepaidAndOtherCurrentAssets
40000
CY2020Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
10000000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1132122
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M1D
dei Entity Registrant Name
EntityRegistrantName
Laird Superfood, Inc.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-1589788
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
670-6796
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
LSF
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
825366
us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2019Q3 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
0
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
825366
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
0
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8874890
dei Entity Address Address Line1
EntityAddressAddressLine1
275 W. Lundgren Mill Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Sisters
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
OR
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001650696
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q3 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34667
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1079878
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20532
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Unaudited interim financial information </div></div></div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">In the opinion of the Company, the accompanying unaudited financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of its financial position and its results of operations, changes in stockholders&#8217; equity and cash flows. The balance sheet as of December&#160;31, 2019 was derived from audited annual financial statements. Operating results for the nine months ended September&#160;30, 2020 are not necessarily indicative of the results expected for the fiscal year ending December&#160;31, 2020. The accompanying unaudited financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the fiscal year ended December&#160;31, 2019 contained in the Company&#8217;s final prospectus for its IPO dated as of September&#160;22, 2020 and filed with the SEC pursuant to Rule 424(b)(4) on September&#160;23, 2020. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company&#8217;s business and evolving market conditions and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments impact allowances for doubtful accounts and returns, inventory obsolescence, valuation allowance for deferred taxes, fair value of stock-based compensation, beneficial conversion feature, and discount on warrants. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Risk </div></div></div></div><div style="text-indent: 4%; font-family: 'times new roman'; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; background: none;"><div style="font-family: 'times new roman'; font-size: 10pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background: none; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash on deposit and cash equivalents. At times, cash and cash equivalents balances may exceed the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurable limits. The Company&#8217;s investment account (recognized as cash and cash equivalents) is with what the Company believes to be a high-quality issuer. The Company has never experienced any losses related to these balances. Non-interest-bearing amounts on deposit in excess of FDIC insurable limits at September 30, 2020 and December 31, 2019 approximated $6,496,983 and $456,104, respectively.</div> </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
721430
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P11M23D

Files In Submission

Name View Source Status
0001193125-20-291793-index-headers.html Edgar Link pending
0001193125-20-291793-index.html Edgar Link pending
0001193125-20-291793.txt Edgar Link pending
0001193125-20-291793-xbrl.zip Edgar Link pending
d55630d10q.htm Edgar Link pending
d55630dex311.htm Edgar Link pending
d55630dex312.htm Edgar Link pending
d55630dex321.htm Edgar Link pending
d55630dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g55630g93f75.jpg Edgar Link pending
lsf-20200930.xml Edgar Link completed
lsf-20200930.xsd Edgar Link pending
lsf-20200930_cal.xml Edgar Link unprocessable
lsf-20200930_def.xml Edgar Link unprocessable
lsf-20200930_lab.xml Edgar Link unprocessable
lsf-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending